| SCHERING PLOUGH C - [Ticker: SGP]|| |
|Última Trade||290,000||Range 52 Semanas||[0,000 - 0,000]|
|Hora da Última Trade||2018-11-13 - 00:00:00||Price-Target 1 Ano||0,000|
|Variação||--59.00 (+0.83%)||Capitalização Bolsista||0 |
|Bid / Ask||N/A||EPS||0,00|
|Volume||160||Volume Médio (3m)||0|
|Nota: Os dados podem apresentar atraso de alguns minutos.|
|Ver cotações de outros activos|
|Últimos 10 Tópicos no Fórum sobre SCHERING PLOUGH C:|
|Não foram encontrados tópicos sobre SCHERING PLOUGH C [SGP], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SCHERING PLOUGH C.|
| Notícias sobre SCHERING PLOUGH C [SGP]: (ordenadas por relevância)|
National Hog Farmer
Snelson named AASV executive directorNational Hog Farmer... Medicine and then spent 10 years as the swine veterinarian for Carroll's Foods in Warsaw, N.C. In 2000, he accepted a position as a swine technical services veterinarian with Schering-Plough Animal Health before leaving in 2003 to become the ...
Anti-Viral Drugs Market 2018-2023 by Region, Manufacturer ...Dacca TimesTop Key Players Segment Analysis: Schering-Plough, Gilead, AstraZeneca, Cipla, Roche, Merck & Co, Bristol-Myers-Squibb, GlaxoSmithKline, Johnson & Johnson, Abbott. Anti-Viral Drugs Market Report Provides Comprehensive Analysis Of: Key Anti-Viral ...e mais »
DOF: 16/11/2018Diario Oficial de la Federacion (Comunicado de prensa)01 004051 GAMESA, SALADAS, CRACKETS, CAJA C/6 ROLLOS DE 417 GR 67.15 KG CAMBIO DE PRESENTACION. 01 004062 ...... 11 197004 CLARITYNE, TABLETAS, 10, DE 10 MG, LAB SCHERING PLOUGH 112.50 CAJA CAMBIO DE MARCA.
Florida Daily Chronicle
Global Anti-Viral Drugs Market Demand 2018-2025: Roche, Abbott ...Florida Daily ChronicleThe report demonstrates the outstanding market players such as Roche, Abbott, AstraZeneca, GlaxoSmithKline, Gilead, Johnson & Johnson, Cipla, Merck & Co, Bristol-Myers-Squibb, Schering-Plough of the global Anti-Viral Drugs market. It presents wide ...e mais »
The Pharmaceutical Journal
Hepatitis C: tackling the silent killerThe Pharmaceutical Journal1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ...
Merck, Schering-Plough set to complete mergerReutersNEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.
Pharma Billionaire Charged With Penny Stock FraudForbesInvestigators allege an investor named Barry C. Honig served as the ringleader of the scheme. In each of three ... They sold that company, the developer of some of the first sustained release formulations, to Schering-Plough in 1986 for $836 million ...e mais »
Snelson Named AASV New Executive DirectorPork MagazineFor the first time in 25 years, the American Association of Swine Veterinarians (AASV) will have a new Executive Director, Dr. Harry Snelson. Snelson, who is the current AASV Director of Communications, has had a long association with the organization ...
Cleveland Daily Banner
Alice Kaye AmesCleveland Daily BannerShe was a student at Bradley High School, and retired from Schering Plough as a secretary. She was dearly loved and will be greatly missed by all who knew her. She is preceded in death by her parents, George Myrick Hewitt and Alfrida Anderson Hewitt; ...e mais »
|Para mais notícias sobre SCHERING PLOUGH C clique aqui:|
Notícias de SCHERING PLOUGH C